Skip to main content

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2345${count})

  • MJFF Research Grant, 2010
    Optimization of Optical Coherence Tomography as a Biomarker for Parkinson's Disease

    Objective/Rationale:
    Determine the thickness of the neural part of the eye, the retina in patients suffering from Parkinson Disease and in healthy, age matched subjects.

    Project Description:
    Patients...

  • MJFF Research Grant, 2010
    Making PSG Databases Available to Researchers

    Objective/Rationale
    Information from clinical trials is not easily available to most researchers, especially if the trials are sponsored by industry. Making information from clinical trials more...

  • Rapid Response Innovation Awards, 2010
    Increasing Endogenous Neurogenesis Using Neurosteroids: A Novel Therapeutic Strategy to Treat Parkinson's Disease

    Objective/Rationale
    We will test a locally produced brain chemical that increases the generation of new neurons to replace the damaged neurons in Parkinson disease (PD). The production of this...

  • Neurotrophic Factor Therapies for Parkinson's Disease, 2010
    CERE-120 Long-Term Subject Follow-Up

    Outcomes of Original Grant:
    Neurotrophic factors including neurturin (NTN) have been shown to effectively augment the function and prevent the death of dopaminergic nigrostriatal neurons in animal...

  • Neurotrophic Factor Therapies for Parkinson's Disease, 2010
    Intermittent Bilateral Intraputamenal Treatment with GDNF

    Objective/Rationale
    Glial cell-derived neurotrophic factor (GDNF) has been shown in various pre-clinical models of Parkinson's disease (PD) to restore damaged nerve cells, including dopamine...

  • Therapeutics Development Initiative, 2010
    Flibanserin in Levodopa-induced Dyskinesia: MPTP-lesioned Pre-clinical Model

    Objective/Rationale
    Different mechanisms of action are considered relevant for provoking the involuntary abnormal jerking and hyperextensive or writhing-like twisting and turning movements called...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.